Suppr超能文献

用于变应原免疫疗法的商业花粉提取物中泛变应原的检测

Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.

作者信息

Asero Riccardo, Mistrello Gianni, Amato Stefano

机构信息

Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, MI, Italy.

Lofarma SpA, R&D, Milan, Italy.

出版信息

Ann Allergy Asthma Immunol. 2016 Aug;117(2):180-5. doi: 10.1016/j.anai.2016.05.010. Epub 2016 May 27.

Abstract

BACKGROUND

Up to 50% of patients with pollen allergy are sensitized to at least 1 of the 2 pollen pan-allergens profilin and polcalcin. These allergens could have clinical relevance but the content of profilin and polcalcin in commercial extracts for allergen immunotherapy (AIT) is unknown.

OBJECTIVE

To detect these pan-allergens in commercial pollen extracts for AIT from various sources.

METHODS

Immunoglobulin E (IgE) reactivity to Phl p 7 and Bet v 2 of sera from 18 adults hypersensitive to profilin and/or polcalcin was investigated by enzyme-linked immunosorbent assay before and after absorption with grass, birch, ragweed, pellitory, and olive pollen extracts for AIT from different producers. Immunoblot inhibition experiments also were carried out using the same allergens.

RESULTS

Birch, grass, ragweed, and olive pollen extracts for AIT contained large amounts of profilin, inducing 80% to 90% inhibition in most cases; Parietaria AIT extract appeared to contain little profilin. On immunoblot, grass and birch pollen extracts for sublingual AIT completely absorbed IgE specific for rBet v 2. Interestingly, only grass pollen extracts induced a significant inhibition of IgE binding to rPhl p 7 on enzyme-linked immunosorbent assay and immunoblot. A grass pollen allergoid lost most of its inhibitory potency, suggesting a much weakened affinity for specific IgE.

CONCLUSION

With the exception of Parietaria, commercial extracts for AIT of most pollens are rich in profilin and, hence, potentially able to desensitize to this allergen; in contrast, only grass pollen extracts seem rich in polcalcin. These are the pollens to use in case of severe symptoms induced by pollen pan-allergens.

摘要

背景

高达50%的花粉过敏患者对2种花粉泛过敏原肌动蛋白结合蛋白和钙结合蛋白中的至少1种致敏。这些过敏原可能具有临床相关性,但用于变应原免疫治疗(AIT)的商业提取物中肌动蛋白结合蛋白和钙结合蛋白的含量尚不清楚。

目的

检测来自不同来源的用于AIT的商业花粉提取物中的这些泛过敏原。

方法

通过酶联免疫吸附测定法,研究了18名对肌动蛋白结合蛋白和/或钙结合蛋白过敏的成年人血清在被不同生产商提供的用于AIT的草、桦树、豚草、墙草和橄榄花粉提取物吸收前后对Phl p 7和Bet v 2的免疫球蛋白E(IgE)反应性。还使用相同的过敏原进行了免疫印迹抑制实验。

结果

用于AIT的桦树、草、豚草和橄榄花粉提取物含有大量肌动蛋白结合蛋白,在大多数情况下诱导80%至90%的抑制;墙草AIT提取物似乎含有很少的肌动蛋白结合蛋白。在免疫印迹上,用于舌下AIT的草和桦树花粉提取物完全吸收了针对rBet v 2的IgE。有趣的是,只有草花粉提取物在酶联免疫吸附测定和免疫印迹中诱导了对IgE与rPhl p 7结合的显著抑制。一种草花粉类变应原失去了大部分抑制效力,表明对特异性IgE的亲和力大大减弱。

结论

除墙草外,大多数花粉的用于AIT的商业提取物富含肌动蛋白结合蛋白,因此可能能够使对该变应原脱敏;相比之下,似乎只有草花粉提取物富含钙结合蛋白。这些是在花粉泛过敏原引起严重症状时使用的花粉。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验